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Dementia is a progressive degenerative condition that currently affects about
700,000 older adults in the UK. Patients with dementia often suffer from
neuropsychiatric symptoms and challenging behaviours, such as agitation,
aggression and psychosis. These can cause major problems for both dementia
patients and their carers, with the latter often reporting high levels of distress and
depressive symptoms.
Antipsychotic drugs, which were developed to treat patients with mental health
problems such as schizophrenia, are now one of the main treatments for managing
behavioural and psychological symptoms in patients with dementia. However,
emerging evidence suggests that, not only do these drugs have few benefits for
patients with dementia, they may pose significant risks, especially if used long-
term, such as an increased risk of falls, blood clots, stroke and heart problems.
For these reasons, the Department of Health is committed to achieving a
significant two-thirds reduction in the use of antipsychotic medication among
patients with dementia. Despite current clinical guidance which recommends the
use of non-pharmacological approaches – that is, treatments or therapies other
than medication – to improve behavioural and psychological symptoms in patients
with dementia, the widespread use of antipsychotics for these patients continues. 
In order to fill this gap in evidence, PIRU was commissioned by the Department of
Health to carry out a systematic review of the effectiveness of non-pharmacological
treatments or therapies for managing neuropsychiatric and challenging behaviours
in patients with dementia. Given the vast literature on this topic, PIRU carried out
an ‘overview’ of reviews which involved examining thirty recent systematic reviews
in order to summarise their results on the effectiveness of alternative treatments.  
In all, 19 non-pharmacological treatments were identified in the systematic reviews.
Of these, the most consistent evidence for effectively managing behavioural and
psychological symptoms was found for behaviour management techniques
delivered by professional staff, and for staff and caregiver training and support. 
There was promising evidence for four other alternative treatments – physical
activity/exercise; massage/touch therapies; multi-sensory stimulation (e.g.
snoezlen, aromatherapy) and music therapy – although the evidence for these
was not as robust, either because the primary studies were not as rigorous, the
results were more mixed or the evidence available was limited.
Only one treatment appeared to be ineffective – validation therapy. 
For the vast majority of treatments, however, the evidence was inconclusive,
either because it was inconsistent across primary studies, or these studies were
of poor quality, or the evidence was almost totally lacking. This general lack of
high quality evidence meant that the systematic reviews included in our overview
refrained from making policy and practice recommendations. It also leads to the
conclusion that more and better research is needed on these alternative
interventions in order to inform future policy and practice.
Summary
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Non-drug treatments for symptoms in dementia
This project was commissioned by the Department of Health (DH) Policy Research
Programme on behalf of the Department’s Older People and Dementia Programme
to support the implementation plan for the National Dementia Strategy (DH 2009)
with regard to the reduction of antipsychotic drugs prescribing. Following an
independent report for the government in November 2009, ministers committed
to achieving an overall two-thirds reduction in the use of antipsychotic medication
within three years. Yet the scientific evidence on the effectiveness, cost-
effectiveness and implementation feasibility of non-pharmacological alternatives to
antipsychotic drug prescribing has not been collected nor assessed systematically.
Without such evidence, current efforts to reduce the prescription of antipsychotic
drugs may be inappropriate, inefficient, clinically ineffective, or result in poor patient
outcomes or experience.
To partially bridge this gap, this project aimed to conduct an overview of the
effectiveness of non-pharmacological interventions – that is, treatments or
therapies that do not involve any medication – specifically for the management of
neuropsychiatric symptoms and challenging behaviours in all types of patients
with dementia. In order to meet this objective, a wide range of non-
pharmacological interventions were examined, along with their outcomes. In this
report, we only summarise the evidence as it relates to our primary outcome of
managing neuropsychiatric symptoms/challenging behaviours. The original plan
was also to include reviews on the cost-effectiveness and implementation
feasibility of non-pharmacological interventions, but a preliminary search found
insufficient evidence to include these.
2.1 The condition
Dementia is a progressive, degenerative condition caused by diseases of the
brain. Whether it occurs alone, in addition to, or as a complication of, chronic
diseases, it is characterised by cognitive and non-cognitive symptoms of variable
frequency and severity. The underlying pathological processes and trajectory
from mild cognitive impairment to dementia are highly heterogeneous, though
typically accompanied by progressive loss of the ability to perform normal
activities of daily living (ADL) and marked by the emergence of neuropsychiatric
and challenging behaviours (Blesa 2004). The symptoms include agitation (i.e.
aggression, restlessness and pacing), usually in the context of distress or anxiety,
irritability, hallucinations, persecutory delusions, confabulations, wandering,
elation, apathy and sleep problems (Ballard et al. 2008; Tariot et al. 1995; Savva
et al. 2009). As many as 60% of community-dwelling people with dementia
(Lyketsos et al. 2000), and up to 80% or more of those living in nursing homes
develop significant psychopathology (Testad et al. 2005; Zuidema et al. 2007).
The lifetime risk of such complications approaches 100% (Testad et al. 2005;
Howard et al. 2001). There are about 700,000 (predominantly older) adults in the
UK with symptoms of dementia, with a national cost, covering both formal and
informal care, of around £17 billion per year (Knapp et al. 2007).
1. Introduction
2. Background
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2.2 The social burden
Neuropsychiatric symptoms and challenging behaviours occur throughout the
course of the disease, have a profound effect on families, and are associated
with more time spent caregiving, higher care costs, greater risk for nursing home
placement, and staff caregivers’ burnout, turnover and morbidity (Gitlin et al.
2010; Black et al. 2004). Informal caregivers (usually family members and friends)
managing behavioural symptoms, often report high levels of distress and
depressive symptoms, particularly those who perceive that they have inadequate
skills to manage such behaviours (Burke et al. 2009; Gitlin et al. 2010; Ballard et
al. 2000). There is also a significant financial strain inflicted on informal caregivers
and the health care system as a result of the adverse effects of neuropsychiatric
symptoms of dementia (Murman et al. 2005; Beeri et al. 2002).
2.3 The use of antipsychotic medication 
As cardinal elements of the illness, neuropsychiatric symptoms and challenging
behaviours are among the most devastating aspects of caring for a dementia
sufferer and represent a major public health concern. 
Efforts to manage problem behaviours typically involve treatments, in particular the
wide use of antipsychotic drugs (Sink et al. 2005; Schneider et al. 2006). However,
a considerable body of evidence regarding the safety, tolerability and efficacy of
these drugs has called into question common prescribing practices with the
suggestion that they yield modest to no benefits while posing a considerable risk
(Banerjee 2009; Ballard et al. 2008). Moreover, common troublesome behaviours
for families (e.g. refusal of care, repetitive vocalizations, argumentation) do not
respond to such pharmacological treatment (Gitlin et al. 2010). 
For these reasons, current guidance is to recommend the use of non-
pharmacological approaches as the initial treatment for behavioural problems in
patients with dementia (NICE/SCIE 2006; American Psychiatric Association 2007;
Banerjee 2009). However, the widespread prescription of antipsychotics to people
with dementia continues, despite the evidence and contrary to the guidance
issued by the Food and Drug Administration (FDA) in the US and by the
Committee on Safety of Medicines (CSM) in the UK (Ballard et al. 2008). 
This project examined 30 recent systematic reviews in order to provide a
comprehensive overview of the effectiveness of non-pharmacological interventions
for managing neuropsychiatric symptoms and challenging behaviours among
patients with different types and severity of dementia in a range of settings. The
conclusions of all recent high quality systematic reviews are summarised and
compared, and knowledge gaps are highlighted, so that the best current evidence
can be made available to policy-makers, commissioners and clinicians. 
3. Objectives 
of this 
overview
Non-drug treatments for symptoms in dementia
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4.1 Review type
We conducted an overview of the findings from systematic reviews on the
effectiveness of non-pharmacological alternatives to the use of antipsychotics in
patients with dementia. 
Overviews of systematic reviews aim to provide a narrative summary of evidence
from two or more systematic reviews at a variety of levels, such as for different
populations, outcomes, conditions, adverse effects or severity of disease (Becker
et al. 2009). Standardised assessment tools and a rigorous methodology were
used to ensure transparency and quality.
4.2 User involvement
Although systematic reviews are increasingly being commissioned to inform policy
development and provide recommendations for practice and research, relatively
few health or social care systematic reviews have involved the public, patients or
service users (Braye et al. 2005; Smith et al. 2009). This report had public
involvement in reviewing and commenting on the draft report. 
4.3 Consultation with stakeholders
This overview was steered by key DH representatives and reviewed by a Peer
Review Group.
4.4 Identification of relevant systematic reviews
The aim was to include all good quality peer-reviewed systematic reviews that
focused on the effectiveness of non-pharmacological interventions in the
management of neuropsychiatric symptoms and challenging behaviours in patients
with dementia. All records of research identified by searches were uploaded to
the specialist systematic review software EPPI-Reviewer for duplicate stripping
and screening (Thomas et al. 2010).
4.4.1 Definitions
•  Systematic reviews were included if they presented a defined search strategy
and explicit inclusion criteria.
•  Types of dementia include Alzheimer’s disease, vascular dementia, fronto-
temporal and Lewy body.
•  Levels of severity include mild, moderate and severe dementia.
•  Non-pharmacological interventions include all types of non-drug interventions
(e.g. psychological, sensory, behavioural, educational or environmental), which
are offered in any of the following settings: community (including home), primary
care, secondary care or care homes. Interventions for informal caregivers (e.g.
education, support, behaviour management) and health care professionals
were also covered. 
4. Review 
methods
Non-drug treatments for symptoms in dementia
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•  Neuropsychiatric symptoms and challenging behaviours include agitation
(i.e. aggression, restlessness and pacing), depression, anxiety, irritability,
hallucinations, persecutory delusions, confabulations, wandering, elation,
apathy and sleep problems AND/OR groups of symptoms and behaviours
as reported in systematic reviews, i.e. psychotic symptoms, behavioural,
neurobehavioral, perceptual and psychomotor disorders.
4.4.2 Outcomes 
Data was extracted and reported for the following outcomes:
•  Use of antipsychotics and/or other psychotropic agents
•  Effect on intensity and/or frequency of neuropsychiatric symptoms and
challenging behaviours.
4.4.3 Inclusion and exclusion criteria for systematic reviews
•  Inclusion criteria:
i)   Population – Systematic reviews that focused on interventions delivered 
to patients who had a diagnosis of dementia confirmed by the use of a
validated cognitive or functional instrument OR by their caregiver AND/OR
by health care professionals caring for patients with dementia. AND
ii)  Intervention – Systematic reviews that assessed non-pharmacological
interventions in the management of neuropsychiatric symptoms and
challenging behaviours. AND
iii)  Control or comparator treatment – Either normal care, no treatment, 
placebo or attention control, or with some noted standard of care. AND
iv) Outcomes – Studies where the efficacy of a non-pharmacological 
intervention was tested on at least one of the outcomes (as described in
section 4.4.2). AND
v) Study design – Any, except single case report. AND
vi) Minimum quality standards – Systematic reviews that met three criteria
of the AMSTAR tool (Shea et al. 2009) (see section 4.6.1). 
•  Exclusion criteria:
Studies were excluded if they:
i)   Had a primarily pharmacological, alternative and/or herbal medicine 
treatment focus. 
ii)  Combined a pharmacological and non-pharmacological treatment. 
iii)  Focused on palliative care or end-of-life (unless the focus was 
specifically on relieving neuropsychiatric or behavioural symptoms of
dementia).
iv) Solely focused on depression, anxiety, sleep dysfunction or sleep 
architecture in dementia (unless other neuropsychiatric or behavioural
symptoms associated with dementia were also covered).
v) Were a single case report.
4.4.4 Search strategy
The main search was conducted (March 2011) in Medline via OVID (1996 to
March week 2 2011), the CDR databases (DARE/NHS EED and HTA; no date
limits) and the Cochrane Database of Systematic Reviews (no date limits) using
Non-drug treatments for symptoms in dementia
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the following key words: 
•  Dementia, Alzheimer, Alzheimer’s disease, AD, Lewy body, VaD
•  Non-pharmacological, psychosocial, psychological 
•  Cognitive or non-directive or sensory or social or behavio* or recreation or
environment* or relaxation or talking or nursing or light or psychosocial or
psychological) adj3 (therap* or activit* or intervention* or modify or modificat*
or program)
•  Complementary therapies, combined modality therapy, recreation, relaxation
therapy, behaviour therapy, psychotherapy, cognitive therapy, phototherapy.
The search was limited to articles published in English. The search results are
presented in Appendix 1. 
4.5 Selecting reviews
Two review authors (JK, LL) independently screened the search results by title
and abstract to identify relevant systematic reviews. The full texts of the reviews
identified as either relevant or possibly relevant from their titles and abstracts
were obtained. A number (n=5) of possibly relevant reviews that were not readily
available online to the reviewers were not included due to time constraints. Two
review authors (JK, LL) selected the relevant reviews by reading the full text
according to the criteria mentioned above, resolving disagreements by discussion.
4.6 Quality assessment and data extraction
4.6.1 Quality assessment
Two different quality assessments must be addressed in an overview of systematic
reviews: the methodological quality of the reviews included, and the quality of the
evidence in these reviews. 
•  Quality of systematic reviews
Two review authors (JK, LL) independently assessed the methodological
quality of the included systematic reviews using three priority criteria of the
AMSTAR tool (Shea et al. 2009; see Appendix 2): 
• Criterion 3: Was a comprehensive literature search performed?
• Criterion 6: Were the characteristics of the included studies provided?
• Criterion 7: Was the scientific quality of the included studies assessed
and documented?
The AMSTAR is a validated tool designed to assess the quality of systematic
reviews and to be used in reviews of reviews to determine if the potentially
eligible reviews meet minimum quality requirements. Any discrepancy between
reviewers was resolved by discussion. 
Non-drug treatments for symptoms in dementia
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•  Quality of the evidence in selected systematic reviews
The quality of the evidence presented in the included systematic reviews was not
reassessed by the authors. Rather, the results were extracted and a narrative
summary was provided of the highest rated evidence presented in each of the
systematic reviews. This was possible because all the included reviews
assessed the quality of their primary studies (meeting AMSTAR criterion 7). For
reviews which used the Oxford Centre for Evidence-Based Medicine Levels of
Evidence to assess quality, the results are presented according to these levels:
4.6.2 Data extraction
Data from each study was extracted using standardized data extraction forms by two
reviewers (JK, LL). They compared responses to all questions and agreed a version
of the data extraction, resolving any differences by discussion and consensus.
4.7 Synthesising the findings across intervention categories
Although the interventions included in this overview are often quite complex and
difficult to categorise, for presentational purposes, they have been grouped into
the following eight broad types:
•  Sensory enhancement and relaxation: The aim of these approaches is to
increase the overall level of sensory stimulation in the environment to
counterbalance any negative impact of sensory deprivation common to the
experience of dementia. These interventions include massage/touch, relaxation
therapies, music therapy, white noise, multi-sensory stimulation (snoezelen),
transcutaneous electrical nerve stimulation (TENS) and light therapy.
•  Social contact (real or simulated): People living with dementia may often
have limited contact with others in their environment. There are a range of
interventions which aim to provide people with access to different forms of social
Non-drug treatments for symptoms in dementia
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1a    Systematic reviews (with homogeneity) of randomized controlled trials
1b   Individual randomized controlled trials (with narrow confidence interval)
1c    “All or none” randomized controlled trials
2a    Systematic reviews (with homogeneity) of cohort studies
2b   Individual cohort study or low quality randomized controlled trials 
(e.g. <80% follow-up)
2c    “Outcomes” research; ecological studies
3a    Systematic review (with homogeneity) of case-control studies
3b   Individual case-control study
4     Case-series (and poor quality cohort and case-control studies)
5     Expert opinion without explicit critical appraisal, or based on physiology, 
bench research or “first principles”
Ref: www.cebm.net/?o=1025
contact. These include real (one to one contact) or simulated (through video or
audiotapes) human interaction, and pet or animal-assisted forms of therapy. 
•  Cognitive and emotional approaches: These interventions include: 
• Validation and reminiscence therapies: These originate in the humanist 
psychology tradition and aim to address the feelings and emotional needs
of patients with dementia (Finnema et al. 2000). Reminiscence therapy uses
tangible prompts (e.g. photographs, household items) and discussion of
past activities and events to stimulate memories and enable people to share
and value their experiences (Woods et al. 2005). Validation therapy is based
on a synthesis of behavioural and psychotherapeutic methods. It is
premised on individual uniqueness and intended to give an opportunity to
resolve unfinished conflicts by encouraging and validating expression of
feelings (Neal et al. 2003; Livingston et al. 2005).
• Reality orientation: Similarly, reality orientation aims to support people 
to manage the difficult feelings and emotions that occur because of the
impact of dementia on cognitive functioning (e.g. mental disorientation,
memory loss and confusion) and attempts to improve self-esteem and self-
worth. It is based on the idea that impairment in orienting information (day,
date, weather, time and use of names) prevents patients with dementia
from functioning well and that reminders can improve functioning (Livingston
et al. 2005).
• Cognitive stimulation: Derived from reality orientation therapy, cognitive 
stimulation therapy uses information processing rather than factual
knowledge to address functional problems and aims at general
enhancement of cognitive and social functioning (Livingston et al. 2005;
Clare et al. 2003). Cognitive training typically involves guided practice on a
set of standard tasks designed to reflect particular cognitive functions, such
as memory, attention, or problem-solving (Clare et al. 2003).
•  Physical activities/exercise: Managing difficult behaviours associated with
dementia can involve structured activities in order to provide people with
meaningful and engaging experiences, such as physical activities, outdoor
walks or engaging in arts and crafts. 
•  Environmental modifications: This covers a range of interventions which aim
to modify the living environment of people with dementia, such as installing
exit barriers to restrict wandering, adapting the visual environment to decrease
agitation, or increasing the overall safety in the home by removing dangerous
kitchen equipment, unplugging electrical equipment or leaving lights on in
places such as the bathroom. 
•  Behaviour management techniques: These include a range of interventions
which aim to increase pleasant events, or to identify and modify factors which
can lead to specific difficult behaviours or their consequences, as well as the
use of communication skills or distraction techniques. 
•  Caregiver training and support: These refer to a broad range of interventions
which aim to change interactions between caregivers and patients with dementia,
including: psycho-education; integrated family support, such as counselling and
advocacy; training in awareness and problem solving; and support groups.
• Special care units: These units have been designed to support the needs of
patients with dementia in nursing homes and residential settings. They typically
Non-drug treatments for symptoms in dementia
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include environmental modifications and provide specialist training to assist staff
in managing patients with challenging behaviours. 
Evidence from high quality reviews (e.g. Cochrane reviews) or studies (RCTs) is
described first. Then, results from other studies are presented and discussed in
light of their methodological and analytical limitations. As far as possible, we have
tried to ascertain the extent to which the same primary studies are included in
multiple reviews.
5.1 Flow of studies through the review
Systematic searches identified 2438 records of potentially relevant systematic
reviews. Following removal of 296 duplicate records, 138 records were considered
to meet the inclusion criteria on the basis of a reading of the title and abstract. When
full copies of research reports were read and quality assessed against the modified
AMSTAR tool, 30 systematic reviews, reported in 31 papers remained to be included
in this report. A further three citations related to this area – a review of reviews, a
review of practice guidelines, and a review of the literature structured around specific
clinical questions – were also identified (and are summarised in section 5.4). 
5.2 Characteristics of included studies
Of the 30 reviews included in the overview, 15 were considered to be ‘broad’
reviews (i.e. evaluating multiple interventions across a range of outcomes) and 15
were ‘narrow’ reviews (i.e. reviews of single interventions). Combined, the broad and
narrow reviews reported on 651 primary studies, many of which overlapped. A total
of 220 mutually exclusive studies provided the data which informed this narrative
overview. Despite having applied quality criteria to select the 30 reviews, the quality
of included primary studies across systematic reviews varied owing to the different
focus and methodological rigour adopted in each review. The analysis deals with
the issue by first presenting results of Cochrane Reviews and/or high quality RCTs,
followed by a more general discussion of the other sources of evidence. 
5.2.1 Description of broad reviews
Overall, 11 of the broad reviews did not either identify or specify the type or stage
of dementia and/or included mixed population groups. The remaining four reviews
focused on patients with graded levels of dementia (e.g. from mild to severe) or
caregivers, both informal and paid staff. One review only included patients with
early stage vascular dementia, one did not specify the level of dementia severity
and the other focused on informal caregivers.  
Ten reviews presented results from primary studies that were conducted in long-
term care settings or where the majority of studies were conducted in such
settings. Only one review evaluated long-term care interventions delivered in the
home. This was a UK review of primary care provision (Robinson et al. 2010). 
5. Results
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The remaining reviews evaluated interventions across a range of settings,
including three which focused on interventions delivered in community settings,
and one in acute settings. The broad reviews are marked by their wide diversity
of interventions and outcomes. However, all of the broad reviews included
studies that measured the impact of interventions on neuropsychiatric symptoms
and/or challenging behaviours. 
5.2.2 Description of narrow reviews
The majority (13) of the narrow reviews included studies in which patients
presented any level of dementia severity. One review did not specify the severity of
dementia, but since it focused on interventions delivered in domestic settings, it is
likely that the population had mild to moderate dementia. Another review focused
on a population with early stage vascular dementia or Alzheimer’s disease. Seven
reviews presented results from primary studies conducted in long-term care
settings or where the majority of primary studies were conducted in such settings.
Two reviews included studies set in the home, and the remainder either did not
report the setting or evaluated interventions across multiple settings.
5.3 Summary of evidence across intervention categories 
The sections below are structured according to intervention category. First, a
table provides a short summary of the evidence for the intervention category,
followed by a more detailed description for specific interventions that fall within
the category. Priority is given to Cochrane reviews and high quality RCTs in
reporting the results. 
The main outcomes of interest are whether: a) there is a reduction in the use 
of antipsychotic (or other psychotropic) medication (section 5.3.1); or 
b) neuropsychiatric symptoms and challenging behaviours are affected by the
intervention (section 5.3.2). 
5.3.1 Evidence summary – Reduction in use of antipsychotics
Only two reviews specifically evaluated the impact of interventions on the use 
of antipsychotic medication (Livingston et al. 2005; Lai et al. 2009). In Livingston et
al. (2005), two of the included primary studies were judged to be level 2b evidence
on the Oxford Centre for Evidence-Based Medicine Levels of Evidence. Neither
study found any change in antipsychotic medication use from either validation
therapy interventions, or caregiver training in behavioural management
techniques. No significant effect on the use of psychotropic drugs was found in
Lai et al’s (2009) Cochrane review on the effect of special care units. 
Non-drug treatments for symptoms in dementia
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5.3.2 Evidence summary – Effective management of neuropsychiatric
symptoms and challenging behaviours
Narrow reviews of sensory enhancement included two reviews of massage and
touch (Harris et al. 2010; Hansen et al. 2006). The Cochrane review by Hansen
et al. (2006) found hand massage decreased agitation (similar findings based
on the same study were also reported in Kong et al. 2009), but that there was
insufficient evidence to draw conclusions about other behavioural outcomes.
Harris et al. (2010) evaluated slow-stroke back massage and hand massage
and found them to be effective in improving physiological and psychological
indicators of relaxation (n=2). Studies that specifically assessed patients with
dementia also found a positive effect on behavioural symptoms.
Therapeutic touch was also found to significantly reduce pacing, but not
wandering (Robinson et al. 2007, n=1). The review by Kverno et al. (2009)
evaluated the effectiveness of ‘craniosacral still point technique’, finding a
significant reduction for physical and verbal agitation for patients with
moderate dementia (n=1), but reported that there was insufficient evidence to
assess the effectiveness of touch therapy on neuropsychiatric symptoms for
patients in the advanced stages of the illness. The review by Olazaran et al. (2010)
identified three additional studies, but did not judge them to be of sufficient quality
to reach conclusions on the use of massage/touch for patients with dementia. 
Non-drug treatments for symptoms in dementia
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Comparisons: i) usual care (e.g. no touch intervention) 
Number of contributing reviews: 6 and primary studies: 9  
Summary of evidence 
Narrow reviews: Based on Hansen’s Cochrane review (2006), one of two
studies provides reliable evidence in favour of massage and touch
interventions for the immediate or short-term reduction of agitated behaviour. 
Other reviews: In addition, one narrow and four broad reviews reported on
massage/touch. A further seven studies were identified which were not
included in Hansen’s Cochrane review. Four of these studies also reported
positive outcomes in favour of massage/touch therapies for improving
behavioural symptoms including reducing agitated behaviour. However, the
methodological quality of these studies needs to be taken into consideration
when interpreting the findings.
Sensory
enhancement 
and relaxation:
Massage/Touch 
Single study: The findings from one RCT suggest that there is no evidence
of a difference of effect between two types of relaxation training techniques
on agitation for patients with dementia.
Sensory
enhancement 
and relaxation:
Relaxation therapy
The broad review by O’Connor et al. (2009) reports findings from one RCT rated
as ‘strong’. The trial compared progressive muscle relaxation training, which relies
on procedural (or motor) memory, with an individualized ‘imaginal relaxation
technique’ that relied on verbal skills, for the treatment of agitation in dementia.
Although the behaviour rating scores on the Alzheimer’s disease scale were lower
for both arms, at 2-month follow-up no significant differences between groups
were found. The authors refrain from reaching a conclusion on the effectiveness
of relaxation therapy from one study and suggest that further research is
conducted in this area. 
Music therapy was evaluated in a Cochrane review by Vink et al. (2003). The
results of these studies point to a positive effect of music therapy on
behavioural problems. For example, two studies, which investigated individually
based receptive music therapy interventions, both found a significant difference
in the frequency of aggressive behaviours. In addition, one of the five studies
evaluating active group music therapy found significant differences in agitation
(measured by sitting/proximity time) and wandering, while another found a
significant decrease in neuropsychiatric symptoms. While one study didn’t detect
significant change in the BEHAVE-AD scale overall, significant differences were
noted on some sub-scales (although no effects were reported at follow-up).
Another 15 studies identified in five other reviews (Kverno et al. 2009, O’Connor
et al. 2009, Opie et al. 1999, Robinson et al. 2007, Sung et al. 2005) also
demonstrated statistically significant effects in reducing agitated behaviours;
however, the findings must be treated with caution due to the methodological
limitations highlighted. In particular, it was not clear in the other five reviews
whether the interventions referred only to therapy delivered by qualified music
therapists, or to less structured therapeutic use of music (or both).
Non-drug treatments for symptoms in dementia
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Comparisons: i) usual care, ii) control intervention to reduce behavioural
problems or iii) patients acting as their own controls  
Number of contributing reviews: 6 and primary studies: 24  
Summary of evidence 
Narrow reviews: A Cochrane review (Vink et al. 2003) reported on the
results of seven RCTs comparing music therapy with a control intervention
to reduce behavioural problems. Although identifying a positive effect, the
authors concluded that the methodological quality and the reporting of the
included studies were too poor to draw any useful conclusions regarding
the effect of music therapy on behavioural problems.  
Other reviews: In addition, one narrow and four broad reviews reported on
music therapy. Combined, these reviews reported on 17 primary studies not
included in Vink et al. (2003). Fifteen of these studies demonstrated
positive outcomes in reducing the occurrence of some types of agitated
behaviour, but all were rated as moderate to low in terms of quality. 
Sensory
enhancement 
and relaxation:
Music therapy
One low quality study on the efficacy of white noise found a statistically significant
reduction in agitation during treatment for patients living with dementia and
acting as their own comparison group (Livingston et al. 2005). Review authors rated
the study as 4, using the Oxford Centre for Evidence-Based Medicine guidelines
which rate studies from 1 to 5 (1 = consistent level of evidence and 5 = troubling
inconsistent or inconclusive studies).
Neither the Cochrane review by Chung et al. (2002) nor the broad review by
O’Connor et al. (2009) found any evidence to support the short- or long-term impact
of snoezelen or multi-sensory stimulation on mood or behavioural outcomes.
However, the review by Livingston et al. (2005) contradicts these findings and
suggests that there is consistent evidence on the short-term benefits of snoezelen
on agitation. Their conclusions are based on two RCTs rated as high quality (one of
which was also included in two other reviews – Boote et al. 2006, Olazaran et al.
2010). Similarly, two high quality RCTs, in a review of the effects of psychosocial
methods on aggressive and apathetic behaviours (e.g. levels of engagement with
the environment), suggest that there is evidence that multi-sensory stimulation
(snoezelen) reduces apathy in people in the later stages of dementia (Verkaik et al.
2005). Findings from seven additional studies (of variable quality) also suggest that
multi-sensory interventions have a positive short-term impact on disruptive and
challenging behaviours and mood; however, the findings were not always
statistically significant (Livingston et al. 2005). Robinson et al. (2007) report a lack
of evidence for the effectiveness of multi-sensory interventions on wandering. 
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Single study: Reported in one broad review, there was a small but significant
effect in reducing agitation during treatment only. However, the study was
judged to be of low methodological quality.
Sensory
enhancement 
and relaxation:
White noise  
Comparisons: i) usual care, ii) activity sessions, iii) reminiscence therapy, 
iv) non-aromatherapy oil or v) patients acting as their own controls  
Number of contributing reviews: 10 and primary studies: 21  
Summary of evidence 
Narrow reviews: The two RCTs included in the Cochrane Review by Chung
et al. (2002) showed no evidence to support the long or short-term effects of
snoezelen or multi-sensory stimulation programs on the behaviour of people
with dementia.
Other reviews: In addition, nine broad reviews also reported on multi-sensory
stimulation. Combined, these reviews reported on 19 primary studies not
included in Chung et al. (2002). Although the majority of studies report positive
findings for the reduction of agitated behaviour, particularly for aromatherapy,
study quality varies and in most cases only short-term outcomes have been
measured.
Sensory
enhancement 
and relaxation:
Multi-sensory/
Sensory stimulation 
Three reviews, which include studies on the efficacy of aromatherapy, found
positive short-term benefits for reducing agitation in both moderate and
advanced stages of dementia. However, the review authors’ caution that, without
extended follow-up, the long-term benefits of aromatherapy remain unclear
(O’Connor et al. 2009, Kong et al. 2009, Kvervno et al. 2009). 
In Cameron et al.’s (2003) Cochrane review, no overall effect of TENS was found
on many of the neuropsychological and behavioural measures evaluated,
either directly after TENS treatment or six weeks after treatment was completed.
Although a number of studies suggest that TENS may produce short lived
improvements in some neuropsychological measures, the limited presentation and
availability of data from these studies does not allow for definite conclusions to be
drawn on the potential benefits of this intervention. A recent review by Olazaran et
al. (2010) identified the same studies; however, due to lack of study quality they
did not report findings or draw any conclusions. 
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Comparisons: i) placebo treatment (disconnected electrodes/no current)
Number of contributing reviews: 2 and primary studies: 6  
Summary of evidence 
Narrow reviews: A synthesis of six RCTs included in the Cochrane review 
by Cameron et al. (2003) did not find any evidence for the effectiveness of
Transcutaneous electrical nerve stimulation (TENS) on neuropsychological 
or behavioural outcomes.
Other reviews: One broad review identified the same set of studies and did not
find sufficient evidence to warrant making any recommendations for practice. 
Sensory
enhancement 
and relaxation:
Transcutaneous
electrical nerve
stimulation (TENS)
Comparisons: i) dim light
Number of contributing reviews: 5 and primary studies: 10  
Summary of evidence 
Narrow reviews: The Cochrane Review by Forbes et al. (2009) identified four
relevant studies but concluded that there is insufficient evidence to determine
whether light therapy is effective in managing behaviour or psychiatric
disturbances associated with dementia. 
Other reviews: Four broad reviews report findings from an additional six
studies on the effectiveness of light therapy on agitation and disruptive
behaviour. Although three reviews report significant improvements in these
outcomes, none of the studies included are of a high enough methodological
quality to make sound recommendations.
Sensory
enhancement 
and relaxation:
Light therapy
The Cochrane review by Forbes et al. (2009) detected no significant effect of
light therapy on behavioural or psychiatric disturbances or depression,
irrespective of the time of the day light therapy was administered (and accounting
for length of treatment). One broad review came to similar conclusions (Kong et al.
2009), and another did not make recommendations (Olazaran et al. 2010). Three
reviews reported a significant reduction in agitation (Ayalon et al. 2006, Opie et al.
1999) and aberrant behaviour (Kverno et al. 2009), but their findings were based
on low quality studies and thus the authors refrained from drawing conclusions on
the effectiveness of light therapy. 
Kong et al. (2009) included one study on the presence of a dog in a meta-
analysis of social contact interventions. The individual effect size showed a small
but significant reduction in agitation for the treatment group compared with
those who had not been exposed to pet therapy. 
One study investigating the impact of one-on-one stimulation on neuropsychiatric
outcomes was included in a meta-analysis with other studies grouped as ‘set-time
interventions’. A significant effect in favour of either the treatment or control group
was not found. Another study on one-on-one stimulation was identified but, since
it did not include a measurement for neuropsychiatric symptoms, it was not
included in the meta-analysis (Vasse et al. 2010). 
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Single study: One review found a significant effect for the presence of a
dog, compared with no dog, on reducing agitation in people with dementia.
Social contact –
real or simulated:
Pets/animal-
assisted therapy
Single study: Reported in one review which failed to find a significant effect
for improving neuropsychiatric symptoms after receiving one-on-one
stimulation.
Social contact –
real or simulated:
One-on-one
stimulation
Comparisons: i) usual care, ii) placebo, iii) preferred music or iv) patients
acting as their own controls
Number of contributing reviews: 4 and primary studies: 8  
Summary of evidence 
Narrow reviews: None 
Other reviews: Four broad reviews included findings from eight primary
studies on the impact of simulated interaction. Three randomised trials
judged as sound indicate that simulated presence can reduce agitation
during treatment. However, no significant differences of effect were found
between groups. The remaining five studies report mixed, non-significant
findings for a range of behavioural outcomes.  
Social contact –
real or simulated:
Simulated
interaction/
Family video 
Three randomised trials, judged to be of sound quality, reported across four
reviews (Kong et al. 2009, Kverno et al. 2009, Livingston et al. 2005, O’Connor
et al. 2009) found that, although simulated presence reduced physical and
verbal agitation during treatment, no significant differences in agitation or
withdrawn behaviours were found between intervention and control groups. 
Five additional controlled trials were also reported in Livingston et al. (2005).
Three of these trials reported non-significant improvement in social interaction
and attention, but not aggressive behaviours, while one study also found that
patients’ well-being deteriorated. The other two single group designs reported
mixed results on anxiety, social interaction and agitated behaviour.
Cognitive stimulation interventions (n=2 RCTs) were evaluated in the Cochrane
review by Clare and Woods (2003), who found no evidence of effectiveness on
behavioural problems. Another review, including two additional studies, also
came to the same conclusion (Livingston et al. 2005). However, a more recent
review by Olazaran et al. (2010), reporting the findings of two RCTs, suggested
that cognitive stimulation group sessions can have a positive effect on the
behaviour of institutionalised patients with dementia. 
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Comparisons: i) structured activities (without any cognitive-based
components), ii) wait lists or iii) medication only 
Number of contributing reviews: 3 and primary studies: 6  
Summary of evidence 
Narrow reviews: Two RCTs included in the Cochrane review by Clare and
Woods (2003) showed no evidence to support the effectiveness of cognitive
training intervention on the behaviour of people with dementia.  
Other reviews: Two broad reviews also report on the impact of cognitive
interventions on behavioural problems. An additional four studies were
identified. Two reviews concur with Clare and Woods (2003), while a third
review finds a positive impact from two RCTs (Olazaran et al. 2010).  
Cognitive and
emotional
approaches: 
Cognitive
stimulation  
Comparisons: i) usual care, ii) reminiscence therapy or iii) patients as their
own controls
Number of contributing reviews: 3 and primary studies: 14  
Summary of evidence 
Narrow reviews: None 
Other reviews: Ten studies were reported in a single review on the efficacy of
reality orientation interventions. The majority of studies reported non-significant
impacts on behavioural outcomes. A further four, low quality, studies also
failed to find any significant changes in depression for people with dementia. 
Cognitive and
emotional
approaches: 
Reality orientation
Ten studies, of variable quality, evaluating the effectiveness of reality orientation
therapies on behavioural outcomes were reported in a single review (Livingston et
al. 2005). The findings were judged to be inconsistent. The results of two RCT’s
diverged, one in favour of the intervention for improving neuropsychiatric
symptoms, while the other did not report any changes in behaviour when
compared with active ward orientation. The remaining seven controlled trials
reported some improvement in decreasing neuropsychiatric symptoms and
delay in being institutionalised, but many failed to find significant differences
between groups (Livingston et al. 2005). Findings from a further four, low quality
studies, reported across three reviews (Bates 2004, Livingston et al. 2005,
Verkaik et al. 2005) also found insufficient evidence that reality orientation
improves depression.  
Regardless of study quality, validation therapy was not found to be effective in
improving behavioural outcomes. No significant evidence of effect was found
for reducing irritability, aggression or improving other types of neuropsychiatric
outcomes, according to the results of seven trials reported across six reviews
(Livingston et al. 2005, Neal et al. 2009, O’Connor et al. 2009, Olazaran et al.
2010, Vasse et al. 2010, Verkaik et al. 2005).
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Comparisons: i) usual care, ii) reality orientation group or iii) social care 
Number of contributing reviews: 6 and primary studies: 7  
Summary of evidence 
Narrow reviews: The Cochrane review by Neal et al. (2009) identified three
trials on validation therapy. The lack of any statistically significant differences
between validation and social contact, or between validation and usual care,
for people with dementia lead the authors to conclude that there is insufficient
evidence on the efficacy of validation therapy.  
Other reviews: Evidence drawn from four trials, reported in five additional
reviews, also found no improvement in challenging or disruptive behaviours
for patients with dementia.  
Cognitive and
emotional
approaches: 
Validation therapy 
Comparisons: i) no treatment or ii) social contact
Number of contributing reviews: 3 and primary studies: 12  
Summary of evidence 
Narrow reviews: None
Other reviews: Three broad reviews included 12 studies on reminiscence
therapy but failed to find consistent evidence of effectiveness, with two reviews
failing to make any practice recommendations for this type of intervention.  
Cognitive and
emotional
approaches: 
Reminiscence
therapy
The review by Livingston et al. (2005) identified five studies evaluating the
effectiveness of reminiscence therapy, three of which were RCTs. Only one found
an improvement in behaviour, but the finding was not significant. Verkaik et al.
(2005) reported findings from two studies (one also included in Boote et al. 2006).
Only one study reported a significant result for lowered (self-reported) depression
scores, but the authors caution that the intervention group had higher scores at
baseline. The review by Olazaran et al. (2010) identified six additional studies, but
judged them to be of insufficient quality to draw inferences about effectiveness. 
Physical activity and exercise interventions were evaluated by five systematic
reviews with behavioural outcomes. The majority of studies, judged to be high to
moderate quality, were reported in one review, which found that physical exercise
programs can be effective in improving agitation, aggression, irritability,
wandering and sleep behaviours (Eggermont et al. 2006). There was also some
evidence to suggest that psychomotor therapy groups may reduce aggression in
nursing home residents diagnosed with probable Alzheimer’s disease. However, no
significant changes were observed for depression or apathy (Verkaik et al. 2005).
One narrow review reported inconsistent findings (Christofolletti et al. 2007), while
another reported a lack of evidence (Forbes et al. 2008) to suggest that physical
motor interventions are effective in improving behavioural outcomes in people
with dementia. A broad review by Opie et al. (1999) identified a single study,
rated as moderate, which looked at the effectiveness of a 90 minute walking
program. Receipt of the intervention led to a statistically significant reduction
in the mean number of aggressive incidents reported on non-activity days. 
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Comparisons: i) usual care, ii) social contact/visits, iii) night time program or
iv) less time-intensive program
Number of contributing reviews: 5 and primary studies: 26 
Summary of evidence 
Narrow reviews: Christofoletti et al. (2007) found discordant results across
studies regarding the effects of motor interventions (i.e. physiotherapy,
occupational therapy and interdisciplinary intervention) on behavioural
outcomes (n=4). The quality of included studies was weak to moderate
according to the authors’ criteria. 
Other reviews: In addition, one narrow and three broad reviews synthesised
findings on physical activity/exercise, including outdoor walks. A further 21
studies investigating the impact of physical activity programs on neuropsychiatric
symptoms and challenging behaviours were identified. Nineteen of these
studies were reported in one review. Many of the studies found a positive
impact on disruptive behaviours, including wandering and aggression. 
Physical activity/
Exercise
Two Cochrane reviews, Hermans et al. (2007) and Price et al. (2001), sought to
evaluate the impact of environmental modifications (e.g. subjective barriers,
such as exit modification) on the prevention of wandering in patients with
dementia, but found no relevant RCTs to include. The review by Livingston et al.
(2005) included two different types of enhanced environmental interventions:  
•  Alterations to the visual environment (e.g. murals, patterns, visual barriers,
signposting, mirrors) resulted in a non-significant reduction in exiting behaviours
including testing doors to leave, agitation and reduced ambulation (n=7 low
quality studies). 
•  Designed environments led to a reduction in anxiety; however, while some
studies reported an increase in aggression (n=2 low quality studies), others
found a reduction (n=2 low quality studies). 
Another review, which also synthesised findings on modifications to the environment,
showed a significant improvement in agitation; however, two of the included studies
were judged to be of only moderate quality, while the third was classified as weak
(Opie et al. 1999).
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Comparisons: Not reported
Number of contributing reviews: 4 and primary studies: 14
Summary of evidence 
Narrow reviews: Neither Hermans et al. (2007) nor Price et al. (2001)
Cochrane reviews found any RCTs or controlled trials of sufficient quality to
assess the effect of subjective exit modifications on the wandering behaviour
of cognitively impaired people.
Other reviews: However, two broad reviews, which included 14 studies,
reported only non-significant improvements in behaviour, mainly from poor
quality studies.
Environmental
modifications
Comparisons: i) usual care, ii) placebo or iii) patients acting as their own controls
Number of contributing reviews: 3 and primary studies: 12
Summary of evidence 
Narrow reviews: None
Other reviews: Three broad reviews report on behaviour management
techniques from 12 primary studies. Six RCTs report statistically significant
reductions in neuropsychiatric symptoms and an improvement in behavioural
outcomes. The remaining studies, mostly low quality, report non-significant
reductions in agitation, disruptive vocalisations, aggressive behaviours and
wandering.
Behaviour
management
techniques
Behaviour management techniques (e.g. therapy emphasising pleasant events,
analysis and modification of antecedents and consequences of behaviours) appear
to have lasting effectiveness for the management of dementia-associated
neuropsychiatric symptoms (Livingston et al. 2005). Improvements in wandering
and behaviour (lower withdrawal, better emotional control and less disruptive
behaviour) were achieved through targeted behavioural interventions (e.g. use
of distraction techniques to mitigate aggressive episodes; an individualised care
routine based on patient preferences) (Robinson et al. 2007, Olazaran et al. 2010;
Livingston et al. 2005).
Several reviews synthesised evaluations of a number of types of caregiver
interventions, such as education and support, to help in the management of
difficult behaviours. Four reviews (Ayalon et al. 2006, Livingston et al. 2005,
Logsdon et al. 2007, Peacock et al. 2003), which identified thirteen studies
(including seven RCT’s), found that in some cases the use of psycho-education
training programs for caregivers had an impact on behavioural outcomes.
However, five reviews (Ayalon et al. 2006, Livingston et al. 2005, Logsdon et al.
2007, Olazaran et al. 2010, O’Connor et al. 2009), which included several RCT’s
(n=9) on the impact of training carers in the use of behaviour management
techniques reported some reduction in symptoms (n=2), but a majority of studies
(n=7) did not find training in these techniques to be effective. 
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Comparisons: None
Number of contributing reviews: 6 and primary studies: 22
Summary of evidence 
Narrow reviews: None
Other reviews: Six broad reviews, identifying 22 studies (18 of which were
RCTs), investigated the impact of staff and caregiver training. The evidence
suggests that some improvements can be found in behavioural outcomes for
people with dementia after caregivers had received psycho-education and/or
training in managing difficult behaviours. However the findings are not consistent
and it is not always possible to identify the precise training components that
contributed to effectiveness. 
Staff and caregiver
training and support
Both the Cochrane review by Lai et al. (2009) and the broader review by
Livingston et al. (2005) included studies (n=4) on special care units and found
some evidence for a reduction in neuropsychiatric and behavioural
problems. Another six studies identified by Livingston et al. (2005) on designed
environments combined with staff training reported only non-significant
effects on reducing behavioural disturbances. The lack of high quality research
and statistically significant results for this latter group of studies lead the authors
to grade findings as inconclusive and to make no further recommendations for
practice (Livingston et al. 2005). 
5.4 Reviews of reviews and guidelines
Two reviews of reviews (Hulme et al. 2010, Vernooij-Dassen et al. 2010) and a
set of practice guidelines (Doody et al. 2001) relevant to dementia were
identified during the systematic search (see Appendix 5). 
The practice guidelines were commissioned by the American Academy of
Neurology in response to growing concerns about an ageing US population who
are likely to increasingly suffer from Alzheimer’s disease, a situation similar to that
in the UK. The guidelines provide a summary of the evidence-base to inform the
management of dementia. They consider the impact of ‘pharmacotherapy’
drugs on cognition and the benefits of educational programs for family members
and staff of long-term care facilities. The recommendations for practice include
the use of antipsychotic medication for agitation and psychosis, as well as
training and education to improve caregiver satisfaction.  
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Comparisons: Not stated 
Number of contributing reviews: 2 and primary studies: 25
Summary of evidence 
Narrow reviews: A Cochrane review conducted by Lai et al. (2009) included
eight non-RCTs evaluating the effectiveness of training, programme activities
or care planning provided in special care units for dementia patients with
behavioural problems. Significant improvements in outcomes for the
intervention group, compared with those who stayed in traditional nursing
homes, were reported in some (but not all) studies. The improved outcomes
included: agitation (at 6, 12 and 18 months); mood and affect (at 3 months);
and neuropsychiatric symptoms (at 3 months).
Other reviews: One broad review (Livingston et al. 2005) also included
studies on providing caregiver training in special care units, with (n=6) and
without (n=4) designed environments. While the former found significant
improvements in behaviour, the latter results were inconclusive.
Special Care Units
The interventions summarised in the two reviews of reviews overlap with this
overview, although their focus and scope differ. One review was concerned with
the effectiveness of psychosocial interventions delivered in long-term care
facilities (Vernooij-Dassen et al. 2010). They found behavioural management
techniques and cognitive stimulation to be effective in reducing behavioural
symptoms and/or depression, and physical exercise to stimulate good behaviour.
The other review looks at non-drug treatments that could potentially be
delivered by informal carers in the home setting (Hulme et al. 2010). In spite of
the mixed evidence and limitations in study designs, the authors concluded that
several interventions were found to be effective for use with particular symptoms
of dementia, including music therapy, hand massage/touch, and physical
activity/exercise. The conclusions of both reviews highlight the lack of a robust
evidence-base in which to make practice recommendations. 
6.1 Discussion
The Department of Health is committed to a significant reduction in the use of
antipsychotic drugs to manage behavioural and neuropsychiatric symptoms in
patients with dementia. However, the scientific evidence on the effectiveness of
alternative treatments which could support this reduction in antipsychotic drug
prescribing is either not available or has not been systematically assessed. PIRU
was asked to bridge this gap by carrying out a review of the effectiveness of
non-pharmacological interventions in the management of neuropsychiatric
symptoms and challenging behaviours in patients with dementia. Given the
widespread literature available on this subject, PIRU opted for carrying out an
overview of existing systematic reviews; in all, thirty systematic reviews, dating
from 1999, were included in this overview. 
Overviews of reviews are becoming an established component in the repertoire
of evidence informed (or based) policy and practice (Smith et al. 2011; Thomson
et al. 2010). Reviewing existing systematic reviews can be a pragmatic solution
to the need for evidence in a timescale that does not allow for a new systematic
review to be undertaken. Such overviews can also encompass a greater breadth
of topic than is practicable within a single systematic review of primary research
(e.g. Caird et al. 2010). As systematic reviews aim to inform policy and practice,
they can be easier and quicker to locate than primary research – making the task
of reviewing them easier than is the case for primary research – and there are
many extensive registers of systematic reviews (e.g. the Cochrane Library, DARE
and DoPHER). Like primary research, systematic reviews can themselves be
conducted to varying degrees of quality; overviews of reviews can take this into
account and base their findings only on the most reliable reviews. Where
overviews of reviews cover an area that has been well covered by systematic
reviews, they are able to make strong claims about the strength of evidence in a
given area, as they are based on many systematic searches of the literature, and
(often) contain a great many studies.
6. Discussion 
and summary
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Though there are many benefits to reviewing systematic reviews, there are also
limitations inherent in this approach. A systematic review is only as good as the
studies it contains; the same applies to an overview of reviews, with the additional
layer of the systematic reviews themselves placed between the reviewer and the
evidence. There may be differences in the approaches used by the included
systematic reviews (e.g. different quality assessment criteria), which make it
difficult for the overview to give a balanced perspective across the research field it
is covering. For this report, quality criteria were applied in selecting the included
reviews, with priority given to RCTs as a means of addressing this limitation. 
A related challenge is that of double-counting, as some primary studies inevitably
appear in multiple reviews. Although this was thoroughly checked by the reviewers,
it can be difficult to eliminate the problem completely. It is also likely that the
overview of reviews will not be as up-to-date as a review of primary studies. The
most recent systematic reviews included in this report were published in 2010,
with the result that any evidence from primary studies published in the last two
years or so is not captured here. 
Congruence between the question asked by the overview of reviews and the
systematic reviews it includes can be another issue, especially when some, but
not all, primary studies within a systematic review are relevant to the overview of
reviews. Additionally, systematic reviews may differ in their interpretation/
understanding of the findings of the primary studies. Sometimes this is apparent
when reviewers disagree with one another as to the findings of a given study, but
often mistakes of this kind will go unnoticed. There is also a risk that any errors
in the systematic reviews (e.g. misrepresentations of the results or quality of the
primary studies) could be replicated in the overview. Finally, the depth of
synthesis that it is possible to conduct is less in an overview of reviews than in a
systematic review, because the reviewer is that much further away from the
original research studies. Rather than being a true synthesis, the findings of an
overview of reviews tend to take the form of thematic summaries of the results of
the systematic reviews they contain. In an overview of reviews, the analyst is
more reliant on the judgements of his/her predecessors than in reviews of
primary studies. A specific challenge for this overview was an inconsistency in
the terminology and categorisations used across the broad reviews to describe
and group the interventions. This, combined with a narrative reporting of results
for the categories of intervention types, made the task of extracting results on
effectiveness particularly difficult for some interventions. 
Being a rapid systematic overview of reviews, this project has the above
strengths and weaknesses together with the additional limitation that it needed
to be done quickly. Its searches were not as extensive as would normally be the
case and so it cannot claim to be comprehensive, either in terms of the findings
it contains, or about any gaps that may be apparent. A less tangible, but still
important, limitation of doing the overview rapidly is that there was less thinking
time available. This may be manifested in, for example, a less well developed
conceptual framework, or a failure always to pick up on the implications of
particular findings. 
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6.2 Summary of the evidence
Altogether, the systematic reviews provided evidence for 19 alternative types of
non-pharmacological interventions. The effectiveness of each of these interventions
is summarised in a table format in Appendix 6. 
Table 6.1 below broadly summarises this evidence by categorising each of the
19 alternative interventions into one of six categories based on: a) the potential
effectiveness of each treatment (i.e. likely to be effective, not likely to be effective,
unclear); and b) the quality of the evidence on which these assessments are
based (good/some evidence vs. poor/little evidence). 
As the table shows, there is good, or at least some, evidence that six of the
alternative interventions have potential to be effective. The most consistent evidence
is found for behavioural management techniques delivered by professional staff,
as well as for paid staff and informal caregiver training and support.  
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Table 6.1 Brief summary of the evidence on the potential effectiveness of non-pharmacological
interventions in managing neuropsychiatric symptoms and challenging behaviours in patients 
with dementia
Good/some
evidence
Potential effectiveness
Unclear
•  Simulated interaction
•  Cognitive stimulation
•  Reminiscence therapy
•  Reality orientation
•  Light therapy
•  Special care units
•  Relaxation therapy
•  White noise 
•  One-on-one stimulation
•  Environmental
modifications 
•  TENS
•  Pet/animal-assisted
therapy
Likely to 
be effective
•  Behaviour management
techniques
•  Staff and caregiver
training and support
•  Massage/touch
•  Music therapy
•  Multi-sensory/sensory
stimulation
•  Physical activity/exercise
Poor/little
evidence
Not likely to 
be effective
•  Validation
therapy
Q
ua
lit
y 
o
f 
th
e 
ev
id
en
ce
There is also promising evidence on the effectiveness of physical activity/exercise,
massage/touch therapies, multi-sensory/sensory stimulation (e.g. snoezelen,
aromatherapy) and music therapy, for reducing neuropsychiatric symptoms,
particularly agitation. However, there remains a lack of rigorous RCT evidence 
for these interventions, and research findings did not always show a significant
impact (or occasionally gave contradictory results). 
Only one intervention, validation therapy, was consistently ineffective for managing
challenging behaviours. 
For the majority of alternative interventions, however, there is either conflicting
evidence on their effectiveness (simulated interaction, cognitive stimulation,
reminiscence therapy, reality orientation, light therapy, special care units), or a
lack of robust evidence (relaxation therapy, white noise, one-on-one stimulation,
environmental modifications, pet/animal-assisted therapy, TENS). For these
interventions, it is not possible to give an indication as to whether or not the
treatment is likely to be effective in managing neuropsychiatric and behavioural
symptoms in patients with dementia or in reducing the use of antipsychotic drugs.
The overall conclusions regarding the effectiveness, or lack thereof, of non-
pharmacological interventions concur with those of the two overviews of reviews
identified in our systematic search (Hulme et al. 2010, Vernooij-Dassen et al.
2010). A general lack of high quality evidence (as judged by the systematic
reviewers) meant that the reviews included in this overview refrained from making
policy and practice recommendations. For many of the non-pharmacological
interventions, this was because there were only one or two studies available.
Even when there were more studies available, the quality of these studies was
often judged to be moderate to low, usually because of the study design, small
sample size and/or reporting issues. A number of the narrow Cochrane reviews
failed to identify any RCTs and, even when they did, they were unable to conduct
statistical meta-analysis due to the heterogeneity of the studies (i.e. with regard
to the type and measurement of outcomes). Although the overview did assess
the quality of included reviews, this assessment for the broader reviews (i.e.
AMSTAR criterion 7) was not always clear-cut and often differed across studies,
making it difficult to ascertain the extent to which findings are trustworthy. Finally,
due to time constraints, a small number of reviews (n=5) that were not available
online were not included in this overview. Although some of these reviews would
probably not have met the quality criteria, it is difficult to assess the impact of
these exclusions on the results. 
The widespread conclusion of the systematic reviews examined in this overview 
is that more and better research is needed on non-pharmacological interventions 
in order to inform future health policy and practice. Such research would include: 
1) conducting trials with robust designs and large enough samples to draw
meaningful conclusions; 2) greater consistency in the terminology used to
describe interventions and in the measurement of patient outcomes; 3) improved
reporting of patient characteristics; and 4) clearer descriptions of the context in
which interventions are delivered to enable a better understanding of issues to
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do with implementation and transferability across care settings. The
methodological and reporting issues are best dealt with by following existing
guidelines for carrying out high quality research. Also, more can be learned from
the literature and current practice regarding the context in which promising
interventions have been tested and implemented. Of course, dementia research
is still constrained by factors such as the participant’s capacity to give informed
consent, pressures on caregivers’ time, and identifying patients for studies
(Hulme et al. 2010), particularly for interventions delivered in the patient’s own
home. Despite these challenges, high quality research on alternatives to
antipsychotics can be done, and should be prioritised, in order to improve the
quality of life of patients with dementia and their caregivers.  
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The following search strategy was used for Medline via OVID.
1     dement*.ti. (24826)
2     alzheimer*.ti. (34576)
3     (dement* or alzheimer* or lewy).ab. (84593)
4     exp dementia/ (96436)
5     ((endpoint* or "end point*" or outcome*) adj6 (dement* or alzheimer* 
or AD or VaD or lewy)).ab. (1072)
6     ((progress* adj5 (dement* or alzheimer* or AD or VaD or lewy)).ab. (5291)
7     or/1-6 (126016)
8     nonpharmacological.ti. (243)
9     ((Cognitive or non-directive or sensory or social or behavio* or recreation 
or environment* or relaxation or talking or nursing or light or psychosocial 
or psychological) adj3 (therap* or activit* or intervention* or modify 
or modificat* or program*)).ab. (64261)
10  (psychosocial or psychological).ti. (40794)
11  complementary therapies/ (11646)
12  combined modality therapy/ (123554)
13  recreation/ (4098)
14  relaxation therapy/ (5326)
15  behavior therapy/ (21030)
16  Psychotherapy/ (37263)
17  cognitive therapy/ (11189)
18  phototherapy/ (4653)
19  nonpharmacological.mp. (1533)
20  or/8-19 (295949)
21  7 and 20 (3547)
22  limit 21 to (“review articles” and “reviews (optimized)”) (1013)
23  limit 22 to (english language and humans) (804)
Appendix 1
Search
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AMSTAR: A measurement instrument tool to assess systematic reviews (Shea 2009)
For this review, systematic reviews were included if they met at least criteria 3, 6 and 7. 
Comments
3  Yes
 No
 Can’t answer
 Not applicable
Was a comprehensive literature search performed?
At least two electronic sources should be searched. The report must include years and databases
used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated, and
where feasible, the search strategy should be provided. All searches should be supplemented by
consulting current contents, reviews, textbooks, specialized registers, or experts in the particular
field of study, and by reviewing the references in the studies found.
4  Yes
 No
 Can’t answer
 Not applicable
Was the status of publication (i.e., grey literature) used as an inclusion criterion?
The authors should state that they searched for reports regardless of their publication type. 
The authors should state whether or not they excluded any reports (from the systematic review),
based on their publication status, language etc.
2  Yes
 No
 Can’t answer
 Not applicable
Was there duplicate study selection and data extraction?
There should be at least two independent data extractors and a consensus procedure for 
disagreements should be in place.
1  Yes
 No
 Can’t answer
 Not applicable
Was an ‘‘a priori’’ design provided? 
The research question and inclusion criteria should be established before the conduct of the review.
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Comments
7  Yes
 No
 Can’t answer
 Not applicable
Was the scientific quality of the included studies assessed and documented?
‘‘A priori’’ methods of assessment should be provided (e.g., for effectiveness studies if the author(s)
chose to include only randomized, double-blind, placebo-controlled studies, or allocation
concealment as inclusion criteria); for other types of studies, alternative items will be relevant.
8  Yes
 No
 Can’t answer
 Not applicable
Was the scientific quality of the included studies used appropriately in formulating
conclusions?
The results of the methodological rigor and scientific quality should be considered in the analysis
and the conclusions of the review, and explicitly stated in formulating recommendations.
6  Yes
 No
 Can’t answer
 Not applicable
Were the characteristics of the included studies provided?
In an aggregated form, such as a table, data from the original studies should be provided on the
participants, interventions, and outcomes. The ranges of characteristics in all the studies analysed,
e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other
diseases should be reported.
5  Yes
 No
 Can’t answer
 Not applicable
Was a list of studies (included and excluded) provided?
A list of included and excluded studies should be provided.
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Comments
11  Yes
 No
 Can’t answer
 Not applicable
Was the conflict of interest included? 
Potential sources of support should be clearly acknowledged in both the systematic review 
and the included studies.
‘‘Can’t answer’’ is chosen when the item is relevant but not described by the authors; ‘‘not applicable’’ is used when 
the item is not relevant, such as when a meta-analysis has not been possible or was not attempted by the authors.
10  Yes
 No
 Can’t answer
 Not applicable
Was the likelihood of publication bias assessed?
An assessment of publication bias should include a combination of graphical aids (e.g., funnel
plot, other available tests) and/or statistical tests (e.g., Egger regression test).
9  Yes
 No
 Can’t answer
 Not applicable
Were the methods used to combine the findings of studies appropriate?
For the pooled results, a test should be done to ensure the studies were combinable, to assess
their homogeneity (i.e., Chi-squared test for homogeneity). If heterogeneity exists, a random
effects model should be used and/or the clinical appropriateness of combining should be taken
into consideration (i.e., is it sensible to combine?).
Appendix 3 Characteristics of systematic reviews with a broad focus (n=15)
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Ayalon 
(2006)
Bates 
(2004)
Boote 
(2006)
Hermans
(2007)
Kong 
(2009)
•  Systematic review –
multiple study designs
•  3 x RCTs
•  6 x Single case design
•  Systematic review –
multiple study designs
•  1 x RCT
•  3 x other non-RCTs
•  Systematic review –
any controlled study
design
•  2 x RCTs
•  4 x non-RCTs
•  Cochrane review
•  RCTs only – none
found
•  Systematic review –
RCTs only
•  7 x RCTs
•  7 x randomised cross-
over designs
•  Home
•  Community based
•  Long-term care setting
•  Acute care setting
•  Acute care setting
(Day hospital)
•  Long-term care setting
•  Acute care setting
(Psychiatric hospital)
•  Home
•  Community based
•  Long-term care setting
(All but one intervention
evaluated in a long-
term care setting.)
Patient (severity not
specified) and carer
Patient with mild or
mild to moderate
dementia
Patient with
moderate to 
severe dementia
Dementia patients 
(severity not
specified)
Dementia patients
with agitation (not
specified further)
Neuropsychiatric &
behavioural symptoms:
•  Neuropsychiatric
symptoms
Mental health: 
•  GDS – Depression (as
measure of well-being)
Neuropsychiatric &
behavioural symptoms:
•  Disruptive behaviour 
Mental health:
•  Mood
Neuropsychiatric &
behavioural symptoms: 
•  Wandering
Neuropsychiatric &
behavioural symptoms:
•  Agitation 
•  Communication
•  Functional outcomes
(e.g. ADL)
•  Cognitive outcomes
•  Functional outcomes: 
– Functional ability 
– Physical performance
– Mobility
•  Cognition
•  Well-being in patient
•  Communication
•  Functional outcomes
•  Quality of life (patient
& carer)
•  Carer strain
•  Behavioural management
techniques
•  Caregiver training
•  Behavioural therapy
(Counselling)
•  Emotion-oriented
approaches
•  Sensory enhancement/
Relaxation 
•  Emotion-oriented
approaches
•  Structured activities
•  No RCTs were identified
•  Sensory enhancement/
Relaxation 
•  Social contact (real or
simulated)
•  Staff training
•  Behaviour management
techniques
Title
Intervention 
type
Other outcomes – not
reported in this review
Outcomes – reported 
in this review 
Intervention
recipient 
Intervention
setting
Review 
characteristics
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Kverno
(2009)
Livingston
(2005)
Logsdon
(2007)
•  Systematic review –
any controlled study
design
•  5  x RCTs 
•  4 x Repeated
measures randomised
cross-over designs
•  6 x Single group
designs
•  8 x other designs 
•  Multiple study designs 
•  Included 162 studies 
•  12 x RCTs
•  Systematic review –
RCTs only
•  14 x RCTs
•  Long-term care setting
•  Settings not clearly
reported but reviewers
assume mostly in long-
term care settings
•  Community based
•  Long-term care setting
Patient with
moderately severe
to very severe
dementia
Dementia patients   
(severity not
specified)
Dementia patients
(severity not
specified)
Informal and paid
caregivers
Neuropsychiatric &
behavioural symptoms: 
•  Agitation
Mental health outcomes:
•  Mood
Neuropsychiatric &
behavioural symptoms:
•  Use of antipsychotics
•  Other psychotropic 
Neuropsychiatric  &
behavioural symptoms: 
•  Range of behavioural
symptoms including
aggression and
agitation
•  Institutionalisation
•  Use of health and
social services
(nursing time)
•  Use of restraints
(physical)
•  Sensory enhancement/
Relaxation 
•  Social contact (real or
simulated)
•  Behavioural therapy
•  Emotion-oriented
approaches
•  Structured activities
•  Medical & nursing care
interventions
•  Environmental modifications
•  Sensory enhancement/
Relaxation 
•  Social contact (real or
simulated)
•  Behavioural therapy
•  Emotion-oriented
approaches
•  Structured activities
•  Environmental modifications
•  Caregiver and staff training
•  Reminiscence therapy 
•  Staff training
Title
Intervention 
type
Other outcomes – not
reported in this review
Outcomes – reported 
in this review 
Intervention
recipient 
Intervention
setting
Review 
characteristics
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O’Connor
(2009)
Olazaran
(2010)
•  Systematic review –
multiple study designs
•  10 x RCTs 
•  15 x repeated
measures/before and
after design
•  Systematic review -
RCTs only
•  179 x RCTs
•  Long-term care setting
(Nursing homes or
long-stay hospital
wards)
•  Multiple settings not
clearly reported
Dementia patients
(severity not
specified) with
significant
behavioural
problems 
Informal caregivers
x 3 studies
Professional carers
x 3 studies
Patient and carer
(not further
specified)
Neuropsychiatric &
behavioural symptoms
Neuropsychiatric &
behavioural symptoms
•  Cognitive outcomes
•  Institutionalisation
•  Physical outcomes
e.g. physical health
•  Functional outcomes 
•  Quality of life (in patient
or caregiver)
•  Use of restraints
(physical)
•  Sensory enhancement/
Relaxation 
•  Social contact (real or
simulated)
•  Structured activities
(Recreation)
•  Environmental modifications
•  Caregiver training (informal
& paid caregivers)
•  Training to nursing home
staff (communication and
behaviour management
techniques)
•  Sensory enhancement/
Relaxation 
•  Behavioural therapy
•  Caregiver training (e.g. CG
education, support, case
management, respite care,
multicomponent)
•  Staff training
•  Reminiscence therapy
•  Support and
psychotherapy
•  Trans-cranial magnetic 
•  Recreation therapy 
•  Stimulation 
•  Combination therapy
•  Multicomponent (not
further described)
Title
Intervention 
type
Other outcomes – not
reported in this review
Outcomes – reported 
in this review 
Intervention
recipient 
Intervention
setting
Review 
characteristics
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Opie 
(1999)
Peacock
(2003)
Robinson
(2007, 2010)
•  Systematic review –
43 studies, multiple
study designs
•  5 x RCTs 
•  16 x other designs
rated as high &
moderate quality
•  Results focused on
those studies
•  Systematic review –
RCTs only
•  11 x RCTs
2007:
•  Systematic review –
multiple study designs
•  8 x RCTs
•  3 x non-RCTs
2010: 
•  Systematic review –
multiple study designs
•  Update of NICE review
2006, but not clear
about the range of
study designs included
•  Community based    
•  Long-term care setting 
•  Acute care setting     
•  Community
2007: 
•  Long-term care setting
Community based
(All but three of the
interventions were
evaluated in long-term
care setting. The others
included day centres)
2010: 
•  Home
•  Primary care provision
Dementia patients
(severity not
specified)
Informal caregivers
2007: 
Mixed populations
with dementia or
Alzheimer’s Disease
2010: 
Patient mild to
moderate dementia
Neuropsychiatric &
behavioural symptoms:
•  Agitation
•  Wandering and pacing
•  Physical aggression
•  Sleep 
•  Verbal disruption
Neuropsychiatric &
behavioural symptoms
Neuropsychiatric &
behavioural symptoms:
•  Wandering
•  Feasibility
(i.e. author assigned
a feasibility score to
different types of
interventions)
•  Institutionalisation
•  Mortality (patient)
•  Quality of life (caregiver)
•  Stress and strain
(caregiver)
2007: 
•  Patient satisfaction
Costs:
•  No cost-effectiveness
studies met inclusion
criteria
Feasibility:
•  Acceptability of
interventions
•  Behavioural therapy
•  Structured activities
•  Combination therapy
•  Environmental modifications
•  Caregiver training
•  Caregiver training
•  Case management
•  Education/skill
development
•  Psychotherapy
2007: 
•  Sensory enhancement /
Relaxation 
•  Behavioural management
therapy
•  Structured activities
2010: 
•  Information provision
•  Carer support, 
•  Case management
Title
Intervention 
type
Other outcomes – not
reported in this review
Outcomes – reported 
in this review 
Intervention
recipient 
Intervention
setting
Review 
characteristics
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Vasse
(2010)
Verkaik
(2005)
•  Systematic review –
any controlled study
design
•  19 studies included
•  Systematic review –
multiple study designs
•  23 studies included
•  Long-term care setting
•  Acute care setting
•  Home
•  Community based
•  Long-term care setting
•  Acute care setting
Patient with any
level of dementia
severity
Patient with any
level of dementia
severity
Carer – non-
professional
Neuropsychiatric &
behavioural symptoms
Neuropsychiatric &
behavioural symptoms:
•  Apathy 
•  Aggression 
Mental health outcomes:
•  Depression
•  Functional outcomes
(e.g. ADL)
•  Communication skills
•  Social contact (real or
simulated)
•  Combination therapy
(Walk and talk)
•  Communication strategies
•  Sensory stimulation
•  Social contact (real or
simulated)
•  Behavioural therapy
•  Structured activities
•  Reminiscence
Title
Intervention 
type
Other outcomes – not
reported in this review
Outcomes – reported 
in this review 
Intervention
recipient 
Intervention
setting
Review 
characteristics
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Non-drug treatments for symptoms in dementia
Cameron
(2003)
Christofoletti
(2007)
Chung
(2002)
•  Cochrane Systematic
review
•  9 x RCTs 
•  Systematic review 
•  10 x RCTs 
•  Cochrane Systematic
review
•  3 x RCTs
•  Any controlled study
design (RCTs and
non-RCTs)
•  Any setting
•  TENS of any kinds
and with any pattern
of duration
•  Home
•  Long-term care setting
•  Not specified 
Any degree of
dementia severity
Any degree of
dementia severity
Any degree of
dementia severity
Mental health outcomes: 
•  Affect
•  Depression
Neuropsychiatric &
behavioural symptoms
Mental health outcomes:
•  Affective status 
Neuropsychiatric &
behavioural symptoms
Mental health outcomes: 
•  Mood
Functional outcomes: 
•  Level of independent
functioning
Cognitive outcomes: 
•  Visual and verbal short-
and long-term memory
and semantic verbal
fluency
•  Physical outcomes:
Circadian rest-activity
rhythm
•  Adverse effects 
•  Drop out
•  Physical outcomes e.g.
physical health
•  Functional outcomes:
ADL, IADL, mobility,
risk of falls 
•  Cognitive outcomes
•  Caregiver’s distress
•  Cognition 
•  Physical outcomes: (i.e.
physiological indices)
•  Client-carer
communication
•  Sensory enhancement/
Relaxation
•  Transcutaneous electrical
nerve stimulation – TENS
•  Structured activities:
motor intervention
(physical activity &
exercise)
•  Sensory stimulation 
•  Snoezelen (multisensory
therapy)
Title
Intervention 
type
Other outcomes – not
reported in this review
Outcomes – reported 
in this review 
Intervention
recipient 
Intervention
setting
Review 
characteristics
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Non-drug treatments for symptoms in dementia
Clare and
Woods 
(2003)
Eggermont
(2006)
•  Cochrane Systematic
review
•  9 x RCTs 
•  Systematic review
•  Multiple study designs:
27 studies, all either
RCT or prospective
matched cohort
studies or other
controlled study design
•  Home
•  Community based
•  Acute care setting
•  Home                      
•  Long-term care setting 
Early stage vascular
dementia and
Alzheimer’s Disease
Any severity of
disease 
Neuropsychiatric &
behavioural symptoms
•  Quality of life in patient
•  Caregiver burden,
strain, coping
Neuropsychiatric &
behavioural symptoms
•  Affective behaviour
Institutionalisation: 
•  Rate of admission
to residential care
Functional outcomes: 
•  ADL
Cognitive outcomes:
•  Rate of progression
of dementia
Use of health and social
services
Mental health outcomes: 
•  Self-reported depression
and anxiety
•  Caregiver depression
& anxiety
Functional outcomes: 
•  Sleep
•  Cognitive training
interventions
•  Physical activity/
Structured activities
Title
Intervention 
type
Other outcomes – not
reported in this review
Outcomes – reported 
in this review 
Intervention
recipient 
Intervention
setting
Review 
characteristics
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Non-drug treatments for symptoms in dementia
Forbes 
(2009)
Forbes
(2008)
Hansen
(2006)
Harris
(2010)
Hermans
(2007)
•  Cochrane Systematic
review
•  8 x RCTs 
•  Cochrane Systematic
review
•  4 x RCTs 
•  Cochrane Systematic
review
•  2 x RCTs
•  Systematic review –
Multiple study designs 
•  2 x systematic reviews
•  6 x RCTs
•  12 x quasi-experimental
•  Cochrane review
•  RCTs only (none
found)
•  Community 
•  Long-term care setting
•  Long-term care
•  Community
•  Any setting
•  Any type of intervention
with at least 3 sessions
•  Any setting
•  Home
Any level of
dementia severity
Mixed types of
dementia and levels
of severity
Any level of severity
Older patients,
irrespective of the
dementia status
Dementia patient
(severity not
specified) 
Neuropsychiatric &
behavioural symptoms
Mental health outcomes:
•  Depression
Neuropsychiatric &
behavioural symptoms
Mental health outcomes:
•  Depression
•  Quality of life
(caregiver)
Neuropsychiatric &
behavioural symptoms
Mood
Depression
Neuropsychiatric &
behavioural symptoms
Neuropsychiatric &
behavioural symptoms:
•  Wandering
Functional outcomes: 
•  ADL
Cognitive outcomes
Institutionalisation
Impact on costs of care
•  Cognition
•  Function (ADL)
•  Mortality (patient and
carer)
•  Cognitive outcomes
•  Physiological variables
•  Psychological variables
•  Sleep
•  Quality of life (patient
and caregiver)
•  Functional outcomes
•  Carer strain
•  Light therapy
•  Structured activity
(i.e. aerobic exercise
training or physical activity
programs offered over any
length of time)
•  Massage and touch
•  Sensory enhancement/
Relaxation
•  Slow-stroke back massage
and hand massage
•  No RCTs were identified
Title
Intervention 
type
Other outcomes – not
reported in this review
Outcomes – reported 
in this review 
Intervention
recipient 
Intervention
setting
Review 
characteristics
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Non-drug treatments for symptoms in dementia
Lai
(2009)
Neal 
(2003)
Price 
(2001)
Sung 
(2005)
Vink 
(2011)
•  Cochrane Systematic
review – Multiple study
designs
•  8 x non-RCTs with
matched controls
•  Cochrane review 
•  3 x RCT’s 
•  Cochrane Systematic
review
•  Multiple study designs
(none found)
•  Systematic review 
•  Multiple study designs
(n=8; 2 x RCTs)
•  Cochrane review –
RCTs only
•  10 x RCTs (Search
conducted until June
2010; update of 2003
review)
•  Special Care Units
(designed to
accommodate needs
of people with
dementia – compared
with other long-term
care settings)
•  Long-term care setting
•  Home
•  Long-term care setting
•  Acute care setting
•  Primary studies all
conducted in long-
term care setting
•  Any settings
Patients with
dementia,
Alzheimer’s Disease
and related
disorders  (level of
severity not further
specified)
Any level of
dementia severity 
Any level of
dementia severity
Any level of severity
but mostly moderate
to severe dementia
Any level of
dementia severity
Neuropsychiatric &
behavioural symptoms
Mental health outcomes:
•  Depression
•  Use of antipsychotics,
other psychotropic
drugs
•  Use of restraints
(physical)
Neuropsychiatric &
behavioural symptoms
Neuropsychiatric &
behavioural symptoms: 
•  Wandering
Neuropsychiatric &
behavioural symptoms
Neuropsychiatric &
behavioural symptoms
Mental health:
•  Anxiety and
depression
•  Quality of life (in patient
or caregiver)
•  Cognitive outcomes 
•  Environmental interventions
•  Caregiver training
•  Staff training
•  Special Care Unit
Note: The SCU is not a single intervention
but a set of related interventions which
include the following components:
admission of residents with dementia;
special selection, training and supervision
of staff members; specially designed
activity programs; family involvement;
specially designed physical environment
that is segregated from other areas.
•  Validation therapy 
•  Environmental modifications
(i.e. subjective barriers)
•  Music therapy
•  Music therapy (any type
of music therapy with at
least five sessions) 
Title
Intervention 
type
Other outcomes – not
reported in this review
Outcomes – reported 
in this review 
Intervention
recipient 
Intervention
setting
Review 
characteristics
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Appendix 5 Characteristics of other review of reviews and practice guidelines (n=3)
Non-drug treatments for symptoms in dementia
Doody
(2001)
•  Systematic
review – multiple
study designs
This is a practice
guideline developed
by the American
Academy  of
Neurology. Relevant
research questions
for this review:
3) Do educational
interventions
improve outcomes
in patients and/or
caregivers?
Controlled
observational
studies.
4) Do other non-
pharmacological
interventions
improve outcomes
in patients and/or
caregivers? RCTs,
observational
studies and other
designs.
Long-term care
setting 
Population not
described (but
intervention
delivered to
patients only) 
Neuropsychiatric &
behavioural symptoms:
•  Agitation
•  Psychosis
Mental Health:
•  Depression
•  Use of
antipsychotics
•  Other psychotropic
drugs 
•  Functional outcomes
(e.g. ADL)
•  Cognitive outcomes
•  Quality of life (in
patient or caregiver)
•  Stress and strain/
burden (caregiver)
•  Institutionalisation
•  Urinary incontinence 
•  Sensory
enhancement
/Relaxation 
•  Social contact
(real or simulated)
•  Behavioural therapy
•  Environmental
modifications
•  Caregiver training
•  Staff training
Title
Intervention 
type
The authors recommend: 
i) the use of antipsychotics for
agitation when manipulations
to the environment do not
work
ii) making educational
programs available to family
caregivers to improve their
quality of life and burden
and to support the delay to
institutionalisation
iii) staff to be more aware 
of the benefits of alternatives
to antipsychotic drugs to
minimise their use
iv) the use of graded
assistance, skills practice,
and positive reinforcement 
to support greater functional
independence.
Overall  recommendations/
conclusion
Other outcomes – not
reported in this review
Outcomes – reported 
in this review 
Intervention
recipient 
Intervention
setting
Review 
characteristics
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Appendix 5 Characteristics of other review of reviews and practice guidelines (n=3)
Non-drug treatments for symptoms in dementia
Hulme
(2010)
Vernooj-
Dassen
(2010)
•  Review of
reviews on non-
pharmacological
approaches for
dementia
potentially
accessed and
delivered by
informal carers 
•  Review of reviews
on a range of
psycho-social
interventions 
Reviewer
assumes a range
of settings, but
may be biased
towards home/
community
settings since
delivered by
informal carers
Long-term care 
People with
mild to severe
dementia
People with
mild to severe
dementia 
Neuropsychiatric &
behavioural symptoms
Neuropsychiatric &
behavioural symptoms
•  Functional outcomes
(e.g. ADL)
•  Cognitive outcomes
•  Functional outcomes
(e.g. ADL)
•  Cognitive outcomes
•  Emotion-oriented
approaches
(Reminiscence
therapy)
•  Environmental
modifications
•  Caregiver and staff
training 
•  Behaviour
management
techniques
•  Counselling
•  Sensory
enhancement
/Relaxation
•  Music therapy 
•  Snoezelen 
•  Behavioural therapy
•  Cognitive skills 
•  Structured activities 
•  Physical exercise 
•  Caregiver and staff
training 
•  Behaviour
management
techniques 
Title
Intervention 
type
The conclusions focused on
the ability of carers to
access alternatives ways of
supporting people with
dementia at no extra cost.
However, to be more
effective, they suggest that
additional training and
support might be useful. 
The authors recommend
further research to be
conducted in the use of
psycho-social interventions
before those responsible for
long-term care of patients
with dementia can consider
these kinds of interventions
when preparing
individualised care plans. 
Overall  recommendations/
conclusion
Other outcomes – not
reported in this review
Outcomes – reported 
in this review 
Intervention
recipient 
Intervention
setting
Review 
characteristics
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Appendix 6 Overall summary table: evidence by type of intervention
This table reports a summary of the findings from the broad and narrow reviews. As far as possible, the overlap in primary studies has been accounted for. 
Massage/Touch
Relaxation therapy
Music therapy
White noise
Narrow reviews = 2: Hansen et al. (2006); Harris and
Richards (2010)
Broad reviews = 4: Kong et al. (2009); Kverno et al. (2009);
Olazaran et al. (2010); Robinson et al. (2007) 
Primary studies = 9
Broad reviews = 1: O’Connor et al. (2009) 
Primary studies = 1
Narrow reviews = 2: Vink et al. (2003); Sung et al. (2005)
Broad reviews = 4: Kverno et al. (2009); O’Connor et al.
(2009); Robinson et al. (2007); Opie et al. (1999) 
Primary studies = 24
Narrow reviews = 1: Livingston et al. (2005)
Primary studies = 1
Six reviews, reporting a total of nine studies, consider the efficacy of massage/touch
therapies on the primary outcomes of interest to this overview. A Cochrane review
reports positive findings on agitation but concludes that, with only one high quality
study available, there is a lack of evidence in this area. Four reviews (one broad, three
narrow) also reported positive outcomes in favour of massage/touch therapies for
improving behavioural symptoms.
Only one study reported in one review found no effect of relaxation therapy on agitation,
limiting the conclusions that can be drawn for this intervention type. 
Six reviews reported evidence from twenty-four studies on the impact of music therapy on
behavioural problems present in patients with dementia. A Cochrane review (n=7 RCTs)
identified a positive effect on behavioural problems, but the quality and reporting of the
included studies was too poor to draw useful conclusions. Fifteen of the 17 studies
included in the other reviews also demonstrated statistically significant effects in reducing
agitated behaviours; again, findings must be treated with caution due to the
methodological limitations of these studies.
Since only one review provided evidence from one low quality study on the efficacy of
white noise on reducing agitation (which showed a small but significant effect during
treatment only), the conclusions that can be drawn for this intervention is limited. 
Intervention type Sources Summary of evidence
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Appendix 6 Overall summary table: evidence by type of intervention
Multisensory/Sensory
stimulation
(aromatherapy;
snoezelen) 
Transcutaneous
electrical nerve
stimulation (TENS)
Light therapy 
Narrow reviews = 1: Chung and Lai (2002) 
Broad reviews = 9: Boote et al. (2006); Kong et al. (2009);
Kverno et al. (2009); Livingston et al. (2005); O’Connor et al.
(2009); Olazaran et al. (2010); Opie et al. (2009); Robinson et
al. (2007); Verkaik et al. (2005) 
Primary studies = 21
Narrow reviews = 1: Cameron et al. (2003) 
Broad reviews = 1: Olazaran et al. (2010) 
Primary studies = 6
Narrow reviews = 1: Forbes et al. (2009)
Broad reviews = 5: Ayalon et al. (2006); Kong et al. (2009);
Kverno et al. (2009); Olazaran et al. (2010); Opie et al. (1999)
Primary studies = 10
Ten reviews identified twenty-one studies evaluating the impact of multisensory
stimulation on neuropsychiatric and behavioural problems. The Cochrane review reported
findings from two studies on snoezelen, finding no evidence of impact. A further nine
reviews reported evidence from an additional nineteen studies on aromatherapy. In
many cases, short-term positive results were found, including reduced agitation and
apathy, and improved mood and psychological well-being. However, the quality of the
studies varied from good to poor and did not always reach statistical significance,
leading the authors to conclude that the long-term impacts are still unknown. 
Six studies evaluating the impact of Transcutaneous electrical nerve stimulation (TENS)
have been synthesised across two reviews. Both reviews came to the same conclusion
that there is no long-term evidence of an effect on behavioural outcomes.
Six reviews report findings from 10 studies on the impact of bright light therapy. Overall,
there is insufficient good quality evidence to determine whether light therapy is effective
in managing behavioural or psychiatric disturbances associated with dementia.
Intervention type Sources Summary of evidence
Sensory enhancement and relaxation
Pets/animal-assisted
therapy
Broad reviews = 1: Kong et al. (2009) 
Primary studies = 1
Evidence from one study, showing a positive impact on the presence of a dog on
agitation, was reported in a single review.
Social contact – real or simulated
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One-on-one
stimulation
Simulated interaction/
Family video
Broad reviews = 1: Vasse et al. (2010) 
Primary studies = 3
Broad reviews = 4: Kong et al. (2009); Kverno et al. (2009);
Livingston et al. (2005); O’ Connor et al. (2009)
Primary studies = 8
Three studies identified in one review examined the impact of one-on-one stimulation on
people with dementia. No significant effects were reported for neuropsychiatric and
behavioural problems.
Four reviews identified a total of eight studies on the impact of simulated interaction on
neuropsychiatric and behavioural outcomes. Three randomised trials judged as sound
indicate that simulated presence can reduce agitation during treatment. However, no
significant differences of effect were found between groups. The remaining five studies
report mixed, non-significant findings for a range of behavioural outcomes.
Intervention type Sources Summary of evidence
Social contact – real or simulated
Cognitive stimulation 
Reality orientation
Narrow reviews = 1: Clare and Woods (2003)
Broad reviews = 2: Livingston et al. (2005); Olazaran et al.
(2010)
Primary studies = 6
Broad reviews = 3: Bates et al. (2004); Livingston et al.
(2005); Verkaik et al. (2005)
Primary studies = 14
Findings from six studies reported in three reviews provide evidence on the effectiveness
of cognitive stimulation programs on behavioural and cognitive outcomes. Two reviews
suggest there is no evidence of effect on behavioural problems and positive but limited
findings on cognitive outcomes. However, one review, conducted more recently,
synthesised results from two RCTs which suggest that there are improvements in both
sets of outcomes. 
Three reviews of 14 studies failed to find any significant improvements in behavioural
symptoms as a result of participating in reality orientation interventions. 
Cognitive and emotional approaches 
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Validation therapy
Reminiscence therapy
Narrow reviews = 1: Neal and Wright (2009)
Broad reviews = 5: Livingston et al. (2005); O’Connor et al.
(2009); Olazaran et al. (2010); Vasse et al. (2010); Verkaik et
al. (2005) 
Primary studies = 7
Broad reviews = 3: Boote et al. (2006); Livingston et al.
(2005); Olazaran et al. (2010)
Primary studies = 12
A total of six reviews and seven studies failed to find a significant impact of validation
therapy on behavioural and neuropsychiatric outcomes. 
Three reviews, of 12 studies, synthesised findings on the effectiveness of reminiscence
therapy; they failed to find significant improvements in behavioural outcomes for people
with dementia.
Intervention type Sources Summary of evidence
Cognitive and emotional approaches 
Physical activity/
Exercise 
Narrow reviews = 3: Christofoletti et al. (2007); Eggermont
et al. (2006); Forbes et al. (2008) 
Broad reviews = 2: Opie et al. (1999); Verkaik et al. (2005) 
Primary studies = 26
Five reviews, three of which focus specifically on physical activity, report outcomes from a
total of 26 studies. Some of the studies overlapped reviews, but the majority were reported
in one review only. The reviews suggest that, even after taking into account methodological
weaknesses, high intensity physical activity programs can have a beneficial impact on
behavioural outcomes. 
Physical activity/Exercise 
Environmental
modifications
Narrow reviews = 2: Herman et al. (2009); Price et al. (2001) 
Broad reviews = 2: Livingston et al. (2005); Opie et al. (1999)
Primary studies = 14
A total of four reviews and fourteen studies on natural and enhanced environments were
identified. None of the studies reported a significant improvement in neuropsychiatric and
behavioural problems. 
Environmental modifications
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Behaviour
management
techniques 
Broad reviews = 3: Livingston et al. (2005); Robinson et al.
(2010); Olazaran et al. (2010) 
Primary studies = 12
The six RCTs, reported in the three reviews, showed significant reductions in
neuropsychiatric symptoms and improvements in behavioural outcomes. The other
studies were mostly low quality, but showed evidence to a similar effect (e.g. reductions
in agitation and aggressive behaviours).
Intervention type Sources Summary of Evidence
Behaviour management techniques 
Staff and caregiver
training and support
Broad reviews = 6: Ayalon et al. (2006); Livingston et al.
(2005); Logsdon et al. (2007); Olazaran et al. (2010);
O’Connor et al. (2009); Peacock et al. (2003)
Primary studies = 22
Evidence on the impact of caregiver training and support interventions were found in six
reviews and reported in 22 studies (including 19 RCTs). There was some indication that
disruptive behaviours could improve as a result of psycho-education and support, but
not when training carers in the use of behaviour management techniques. Overall, it
was not always clear precisely what types of training were being provided.
Staff and caregiver training and support
Special Care Units Narrow reviews = 1: Lai et al. (2009)
Broad reviews = 1: Livingston et al. (2005)
Primary studies = 25
Twenty-five studies investigating the impact of psycho-social interventions delivered in
special care units were included in two reviews. Both reviews reported a reduction in
neuropsychiatric symptoms, although findings were not always significant.
Special Care Units
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